Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: Long-Term Follow-Up of Deformations and

Kenichiro Suwa1, Kazuto Ohno1, Terumori Satoh1

  • 1Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Insights

Alcohol septal ablation (ASA) improves heart function in hypertrophic obstructive cardiomyopathy (HOCM) patients, enhancing systolic and diastolic performance. Cardiac MRI reveals these benefits, showing improved LV function and associated diastolic vortex changes.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Cardiovascular Research

Background:

  • Hypertrophic obstructive cardiomyopathy (HOCM) pathophysiology requires detailed hemodynamic and morphologic evaluation.
  • Alcohol septal ablation (ASA) is a treatment for HOCM, necessitating assessment of its effects.

Purpose of the Study:

  • To investigate global cardiac volume, myocardial deformation, and hemodynamics before and after ASA in HOCM patients.
  • To assess long-term follow-up changes post-ASA using advanced MRI techniques.

Main Methods:

  • Retrospective study of 23 HOCM patients undergoing MRI before and after ASA.
  • Utilized 3T MRI with cine, inversion recovery-prepared fast gradient echo, and 4D flow sequences.
  • Assessed global LV volume, myocardial strain (feature-tracking), and hemodynamics (4D flow MRI).

Main Results:

  • Significant increase in global radial strain (16.6% to 20.1%) and decrease in global longitudinal strain (-10.5% to -12.1%) post-ASA.
  • Significant increase in diastolic LV anterior vortex area after ASA (2256.1 to 3826.1 mm²).
  • Correlation found between LV volume/deformation parameters and diastolic LV anterior vortex area (Rs=0.43).

Conclusions:

  • Feature-tracking and 4D flow MRI demonstrate improved systolic and diastolic LV function after ASA.
  • Diastolic LV vortex is linked to LV volume and deformation parameters.
  • Comprehensive cardiac MRI aids in understanding the beneficial effects of ASA on HOCM.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
335
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
399
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
283